The question most patients get wrong
Most patients come to consultation having already decided they want "laser" for their acne scars — without knowing that "laser" covers a range of fundamentally different technologies with very different mechanisms, downtime profiles, and outcomes. RF microneedling and CO2 laser resurfacing are both effective for acne scars, but they work differently and are right for different patients.
The choice between them is not about which is better in the abstract. It is about which is better for your specific scar types, your skin tone, your schedule, and the result you want — and over what timeframe.
How each works
RF microneedling (PiXel8 at Plump) uses insulated microneedles to deliver radiofrequency energy directly into the dermis — below the skin surface. The needles create micro-channels and the RF energy heats the tissue at depth, triggering collagen remodeling and skin tightening. Because the energy is delivered below the surface, the epidermis remains largely intact, which is why downtime is minimal and the risk of pigmentation changes in darker skin is low.
CO2 laser resurfacing works by ablating — literally vaporizing — the outer layers of skin with precision laser energy. Fractional CO2 targets columns of tissue while leaving surrounding skin intact to support healing. The heat simultaneously tightens the dermis and triggers collagen remodeling. Because CO2 laser works on and through the skin surface, it is more powerful per session — and carries more downtime and higher pigmentation risk for darker skin tones.
Which should you choose?
The decision comes down to five factors: scar severity, skin tone, downtime tolerance, pace of results, and whether you're treating in isolation or as part of a combination protocol.
The most common scenario I see in consultation is patients who have had multiple RF microneedling sessions elsewhere and feel they've plateaued. Often this is because their primary issue is boxcar scarring with sharp edges — which RF cannot fully address. In those cases, one well-executed fractional CO2 session produces more improvement than three additional RF sessions. The reverse is also true: fair-skinned patients with rolling scars who've had CO2 laser without subcision have addressed the surface but not the underlying tethering. The device is secondary to the diagnosis.
Skin type — the most important factor
Fitzpatrick skin type classification is the starting point for any laser or device selection. Patients with Fitzpatrick type I–III (fair to medium-light skin) are generally good candidates for CO2 laser. Patients with Fitzpatrick type IV–VI (medium-dark to dark skin) carry a meaningful risk of post-inflammatory hyperpigmentation — darkening of the skin following the inflammatory response to laser energy — that can be more visible and persistent than the original scarring.
RF microneedling bypasses this risk almost entirely because the energy is delivered through insulated needles below the surface, leaving the melanin-rich epidermis largely intact. For patients with skin of color, RF microneedling is the default recommendation at Plump unless there is a compelling clinical reason to use CO2 with appropriate pre- and post-treatment protocols.
The combination protocol
At Plump, the combination of PiXel8 RF microneedling and fractional CO2 laser in a single session is available for $700. This protocol addresses both dermal remodeling (RF's strength) and surface resurfacing (CO2's strength) in the same appointment. It is most appropriate for fair-skinned patients with moderate mixed scarring who can accommodate 7–10 days of combined downtime.
This combination is also frequently performed as part of the acne scar subcision protocol — subcision releases the tethers, Sculptra fills the volume, and the laser combination addresses the surface. It represents the most comprehensive approach to mixed acne scarring currently available.
A note on results timeline. Both RF microneedling and CO2 laser produce collagen remodeling that continues for 3–6 months after treatment. The redness and visible healing that occurs in the first 1–2 weeks is not the result — it is the healing process. Final improvement is assessed at 3 months, not 3 weeks. Patients who judge their outcome at the 6-week mark are often underestimating their result.